Name: Tharimmune, Inc. (THAR) Financial Statements
Creator: FinSpry

Tharimmune Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scale:

Scroll to see more

Tharimmune, Inc. income statement - Annual data in millions USD
Breakdown	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Revenue & Gross Profit
Revenue	0.00	0.00	0.00	0.00	0.00
Cost of Revenue	0.00	0.00	0.00	0.00	0.00
Gross Profit	0.00	0.00	0.00	0.00	0.00
Operating Expenses
Research & Development	6.39	3.56	2.28	1.84	0.85
Selling, General & Administrative	6.04	5.90	4.60	1.37	0.67
Operating Expenses	12.43	9.46	6.88	3.21	1.52
Operating Income	-12.43	-9.46	-6.88	-3.21	-1.52
Other Income/Expense
Interest Income	0.25	0.15	0.00	0.00	0.00
Interest Expense	-0.01	-0.02	1.59	0.83	-0.25
Other Income/Expense	0.24	0.00	0.00	1.83	0.00
Income
Income Before Tax	-12.20	-9.32	-8.47	-2.21	-2.42
Income Tax Expense	0.00	0.00	0.00	0.00	0.00
Net Income	-12.20	-9.32	-8.47	-2.21	-2.42
Net Income - Continuous Operations	-12.20	-9.32	-8.47	-2.21	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00
EBITDA	-12.18	-9.30	-6.88	-1.38	0.00
EBIT	-12.43	-9.46	-6.88	-1.38	-1.52
Depreciation & Amortization	-0.22	0.00	0.00	0.00	0.00
Earnings Per Share
Basic EPS	-9.00	-107.00	-281.00	-80.00	-143.00
Diluted EPS	-9.00	-107.00	-281.00	-80.00	-143.00
Basic Shares Outstanding	1.30	0.09	0.03	0.03	0.02
Diluted Shares Outstanding	1.30	0.09	0.03	0.03	0.02